Abstract
BackgroundDexmedetomidine (DEX) is a novel, highly selective α2-adrenoceptor agonist that elicits sedative, amnestic, sympatholytic and analgesic effects in patients. Several Japanese investigators have reported the clinical usefulness of DEX for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have